ReviewSafety and health at work2026
Occupational Benzene Exposure and Hepatobiliary and Pancreatic Cancers: A Systematic Review and Meta-analysis.
Review in Safety and health at work, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Evidence on the association between benzene and hepatobiliary and pancreatic cancers is scarce. Hence, we aimed to summarize current literature on the association between occupational benzene exposure and these cancers. We conducted a systematic review and meta-analysis by searching Pubmed, Embase, and Scopus through April 2024 to identify cohort and nested case-control studies. We evaluated study quality with the Newcastle-Ottawa Scale and estimated pooled relative risks (RRs) and 95% confidence intervals (CIs) using Paule-Mandel method. Twenty-nine studies were included in the meta-analysis. Occupational benzene exposure was associated with hepatobiliary cancer incidence (RR: 1.14; 95% CI: 1.04-1.24; I
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.